𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of CCNU with benznidazole for metastatic malignant melanoma

✍ Scribed by Norman M. Bleehen; J. Trevor Roberts; Hugh F.V. Newman

Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
269 KB
Volume
12
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with trimetrexate: A phase II study
✍ Odujinrin, Oluwole ;Goldberg, David ;Doroshow, James ;Leong, Lucille ;Margolin, πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

## Abstract Trimetrexate glucuronate, a nonclassical antifolate, was administered to 14 patients with recurrent and progressive metastatic malignant melanoma. Thirteen patients were evaluable for response and toxicity. Five patients had received prior treatment consisting of immunotherapy (one pati

A phase II study of spirogermanium in pa
A phase II study of spirogermanium in patients with metastatic malignant melanoma
✍ Elizabeth Eisenhauer; Ian Kerr; Audley Bodurtha; Neill Iscoe; Peter McCulloch; K πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 205 KB

The National Cancer Institute of Canada Clinical Trials Group conducted a phase II study of spirogermanium given daily for 5 days every 3 weeks to previously untreated patients with malignant melanoma. In 21 evaluable patients one complete response was seen (response rate 5%). Disease progression oc